igforum.bio / spinal-muscular-atrophy-sma-life-expectancy-types-0-1-2-3-and-4 - 176617
A
%Start Spinal muscular atrophy (SMA) life expectancy: Types 0, 1, 2, 3, and 4 Health ConditionsHealth ConditionsAlzheimer's & DementiaAnxietyArthritisAsthma & AllergiesBreast CancerCancerCardiovascular HealthCOVID-19Dermatology & SkincareDiabetesEnvironment & SustainabilityExercise & FitnessEye HealthHeadache & MigraineHealth EquityHIV & AIDSHuman BiologyInflammatory Bowel DiseaseLeukemiaLGBTQIA+Men's HealthMental HealthMultiple Sclerosis (MS)NutritionParkinson's DiseasePsoriasisSexual HealthWomen's HealthDiscoverNewsLatest NewsOriginal SeriesMedical MythsHonest NutritionThrough My EyesNew Normal HealthPodcastsHow to understand chronic painWhat is behind vaccine hesitancy?The amazing story of hepatitis C, from discovery to cureNew directions in dementia researchCan psychedelics rewire a depressed, anxious brain?Why climate change matters for human healthToolsGeneral HealthDrugs A-ZHealth HubsHealth ToolsBMI Calculators and ChartsBlood Pressure Chart: Ranges and GuideBreast Cancer: Self-Examination GuideSleep CalculatorHealth ProductsAffordable Therapy OptionsBlood Pressure MonitorsDiabetic SuppliesFitness TrackersHome GymsGreen Cleaning ProductsHow to Shop for CBDQuizzesRA Myths vs FactsType 2 Diabetes: Managing Blood SugarAnkylosing Spondylitis Pain: Fact or FictionConnectAbout Medical News TodayWho We AreOur Editorial ProcessContent IntegrityConscious LanguageNewslettersSign UpFollow UsMedical News TodayHealth ConditionsDiscoverToolsConnectSubscribe
 What is the life expectancy for spinal muscular atrophy  SMA  Medically reviewed by Heidi Moawad, M.D. — By Zawn Villines on September 12, 2022Spinal muscular atrophy (SMA) is the leading genetic cause of infant mortality. Historically, the average life expectancy for infants diagnosed before 6 months was under 2 years, but new treatments can prolong their lifespan.
%Start Spinal muscular atrophy (SMA) life expectancy: Types 0, 1, 2, 3, and 4 Health ConditionsHealth ConditionsAlzheimer's & DementiaAnxietyArthritisAsthma & AllergiesBreast CancerCancerCardiovascular HealthCOVID-19Dermatology & SkincareDiabetesEnvironment & SustainabilityExercise & FitnessEye HealthHeadache & MigraineHealth EquityHIV & AIDSHuman BiologyInflammatory Bowel DiseaseLeukemiaLGBTQIA+Men's HealthMental HealthMultiple Sclerosis (MS)NutritionParkinson's DiseasePsoriasisSexual HealthWomen's HealthDiscoverNewsLatest NewsOriginal SeriesMedical MythsHonest NutritionThrough My EyesNew Normal HealthPodcastsHow to understand chronic painWhat is behind vaccine hesitancy?The amazing story of hepatitis C, from discovery to cureNew directions in dementia researchCan psychedelics rewire a depressed, anxious brain?Why climate change matters for human healthToolsGeneral HealthDrugs A-ZHealth HubsHealth ToolsBMI Calculators and ChartsBlood Pressure Chart: Ranges and GuideBreast Cancer: Self-Examination GuideSleep CalculatorHealth ProductsAffordable Therapy OptionsBlood Pressure MonitorsDiabetic SuppliesFitness TrackersHome GymsGreen Cleaning ProductsHow to Shop for CBDQuizzesRA Myths vs FactsType 2 Diabetes: Managing Blood SugarAnkylosing Spondylitis Pain: Fact or FictionConnectAbout Medical News TodayWho We AreOur Editorial ProcessContent IntegrityConscious LanguageNewslettersSign UpFollow UsMedical News TodayHealth ConditionsDiscoverToolsConnectSubscribe What is the life expectancy for spinal muscular atrophy SMA Medically reviewed by Heidi Moawad, M.D. — By Zawn Villines on September 12, 2022Spinal muscular atrophy (SMA) is the leading genetic cause of infant mortality. Historically, the average life expectancy for infants diagnosed before 6 months was under 2 years, but new treatments can prolong their lifespan.
thumb_up Like (0)
comment Reply (1)
share Share
visibility 634 views
thumb_up 0 likes
comment 1 replies
N
Natalie Lopez 3 minutes ago
The above information comes from a 2018 study in the Journal of Pediatrics and Child Health. It is i...
E
The above information comes from a 2018 study in the Journal of Pediatrics and Child Health. It is important to note that different types of SMA have different outlooks.
The above information comes from a 2018 study in the Journal of Pediatrics and Child Health. It is important to note that different types of SMA have different outlooks.
thumb_up Like (36)
comment Reply (1)
thumb_up 36 likes
comment 1 replies
J
Julia Zhang 2 minutes ago
Types 0 and 1, the most severe forms, have a very short life expectancy without treatment. However, ...
J
Types 0 and 1, the most severe forms, have a very short life expectancy without treatment. However, newer treatments can prolong the life of someone with type 0 and type 1.
Types 0 and 1, the most severe forms, have a very short life expectancy without treatment. However, newer treatments can prolong the life of someone with type 0 and type 1.
thumb_up Like (9)
comment Reply (1)
thumb_up 9 likes
comment 1 replies
Z
Zoe Mueller 6 minutes ago
Type 2 can cause significant disability, which can increase the risk of a shortened lifespan. Types ...
C
Type 2 can cause significant disability, which can increase the risk of a shortened lifespan. Types 3 and 4 do not substantially affect life expectancy, but complications can sometimes be life threatening. Read on to learn more about SMA life expectancy, factors that affect it, how to improve it, and more.
Type 2 can cause significant disability, which can increase the risk of a shortened lifespan. Types 3 and 4 do not substantially affect life expectancy, but complications can sometimes be life threatening. Read on to learn more about SMA life expectancy, factors that affect it, how to improve it, and more.
thumb_up Like (35)
comment Reply (2)
thumb_up 35 likes
comment 2 replies
M
Mason Rodriguez 5 minutes ago
SMA life expectancy  Share on PinterestKathrin Ziegler/Getty ImagesSMA is a group of diseases that ...
N
Noah Davis 7 minutes ago
Types 0, 1, and 2 cause weakness in the muscles that control breathing, shortening a person’s life...
J
SMA life expectancy 
Share on PinterestKathrin Ziegler/Getty ImagesSMA is a group of diseases that harm motor neurons in the brainstem and spinal cord. It causes muscle weakness and dysfunction that can affect a person’s ability to move, sit, breathe, eat, walk, and talk. There are five types ranging from 0 to 4, and a person’s life expectancy mainly depends on the type of disease they have.
SMA life expectancy  Share on PinterestKathrin Ziegler/Getty ImagesSMA is a group of diseases that harm motor neurons in the brainstem and spinal cord. It causes muscle weakness and dysfunction that can affect a person’s ability to move, sit, breathe, eat, walk, and talk. There are five types ranging from 0 to 4, and a person’s life expectancy mainly depends on the type of disease they have.
thumb_up Like (16)
comment Reply (1)
thumb_up 16 likes
comment 1 replies
J
Joseph Kim 10 minutes ago
Types 0, 1, and 2 cause weakness in the muscles that control breathing, shortening a person’s life...
D
Types 0, 1, and 2 cause weakness in the muscles that control breathing, shortening a person’s lifespan. Type 2 has less of an effect on respiration than types 0 and 1.
Types 0, 1, and 2 cause weakness in the muscles that control breathing, shortening a person’s lifespan. Type 2 has less of an effect on respiration than types 0 and 1.
thumb_up Like (15)
comment Reply (0)
thumb_up 15 likes
E
Conversely, types 3 and 4 can cause various disabilities, including mobility impairments, but they do not significantly affect lifespan. While historical data point to a very shortened lifespan for infants with types 0, 1, and 2, new gene therapies, such as Zolgensma (onasemnogene abeparvovec-xioi), can prolong life expectancy.
Conversely, types 3 and 4 can cause various disabilities, including mobility impairments, but they do not significantly affect lifespan. While historical data point to a very shortened lifespan for infants with types 0, 1, and 2, new gene therapies, such as Zolgensma (onasemnogene abeparvovec-xioi), can prolong life expectancy.
thumb_up Like (21)
comment Reply (0)
thumb_up 21 likes
C
They prevent further lung damage by slowing the progression of the disease. Gene therapy is an approved treatment for children with an SMA diagnosis who are younger than 2 years old and have mutations in the survival 6516 motor neuron 1 (SMN1) gene.
They prevent further lung damage by slowing the progression of the disease. Gene therapy is an approved treatment for children with an SMA diagnosis who are younger than 2 years old and have mutations in the survival 6516 motor neuron 1 (SMN1) gene.
thumb_up Like (37)
comment Reply (3)
thumb_up 37 likes
comment 3 replies
Z
Zoe Mueller 38 minutes ago
Researchers have not proven it to be beneficial for people with SMA who are older than 2 years. The ...
D
David Cohen 30 minutes ago
These two medications restore the missing SMA protein. They work similarly, so doctors do not need t...
E
Researchers have not proven it to be beneficial for people with SMA who are older than 2 years. The injectable medications Spinraza (nusinerson) and Evrysdi (risdiplan) work differently than gene therapy and have approval for use in children and adults.
Researchers have not proven it to be beneficial for people with SMA who are older than 2 years. The injectable medications Spinraza (nusinerson) and Evrysdi (risdiplan) work differently than gene therapy and have approval for use in children and adults.
thumb_up Like (25)
comment Reply (3)
thumb_up 25 likes
comment 3 replies
I
Isaac Schmidt 27 minutes ago
These two medications restore the missing SMA protein. They work similarly, so doctors do not need t...
I
Isaac Schmidt 26 minutes ago
SMA type 0 Type 0 causes symptoms immediately at birth. Before birth, it can also cause symptoms, su...
M
These two medications restore the missing SMA protein. They work similarly, so doctors do not need to combine them, but they can use the medications with gene therapy. Life expectancy by type 
There are five types of SMA, and their outlook and treatment options vary by type.
These two medications restore the missing SMA protein. They work similarly, so doctors do not need to combine them, but they can use the medications with gene therapy. Life expectancy by type  There are five types of SMA, and their outlook and treatment options vary by type.
thumb_up Like (3)
comment Reply (2)
thumb_up 3 likes
comment 2 replies
M
Mason Rodriguez 19 minutes ago
SMA type 0 Type 0 causes symptoms immediately at birth. Before birth, it can also cause symptoms, su...
R
Ryan Garcia 16 minutes ago
Although type 0 is the most severe form of SMA, it is also the rarest. Infants with this type do not...
W
SMA type 0
Type 0 causes symptoms immediately at birth. Before birth, it can also cause symptoms, such as very limited movements of the growing fetus. Most notably, it can lead to respiratory failure.
SMA type 0 Type 0 causes symptoms immediately at birth. Before birth, it can also cause symptoms, such as very limited movements of the growing fetus. Most notably, it can lead to respiratory failure.
thumb_up Like (39)
comment Reply (3)
thumb_up 39 likes
comment 3 replies
I
Isaac Schmidt 11 minutes ago
Although type 0 is the most severe form of SMA, it is also the rarest. Infants with this type do not...
C
Charlotte Lee 3 minutes ago
Emerging treatments, including gene therapy, may prolong life expectancy. However, these treatments ...
S
Although type 0 is the most severe form of SMA, it is also the rarest. Infants with this type do not typically live past their first few months of life, and some do not survive past birth.
Although type 0 is the most severe form of SMA, it is also the rarest. Infants with this type do not typically live past their first few months of life, and some do not survive past birth.
thumb_up Like (32)
comment Reply (2)
thumb_up 32 likes
comment 2 replies
D
Daniel Kumar 10 minutes ago
Emerging treatments, including gene therapy, may prolong life expectancy. However, these treatments ...
L
Lily Watson 2 minutes ago
SMA type 1 Type 1 is the most common form of the disease. According to existing data, an infant with...
L
Emerging treatments, including gene therapy, may prolong life expectancy. However, these treatments are new and work best when they begin before symptoms become severe. It is not clear how they may help infants with type 0 SMA.
Emerging treatments, including gene therapy, may prolong life expectancy. However, these treatments are new and work best when they begin before symptoms become severe. It is not clear how they may help infants with type 0 SMA.
thumb_up Like (5)
comment Reply (1)
thumb_up 5 likes
comment 1 replies
I
Isabella Johnson 15 minutes ago
SMA type 1 Type 1 is the most common form of the disease. According to existing data, an infant with...
Z
SMA type 1
Type 1 is the most common form of the disease. According to existing data, an infant with this type has an average lifespan of 2 years or less. Symptoms usually begin between 3 and 6 months after birth.
SMA type 1 Type 1 is the most common form of the disease. According to existing data, an infant with this type has an average lifespan of 2 years or less. Symptoms usually begin between 3 and 6 months after birth.
thumb_up Like (41)
comment Reply (2)
thumb_up 41 likes
comment 2 replies
S
Sebastian Silva 14 minutes ago
Breathing difficulties are common and, in many cases, eventually fatal. As mentioned earlier, new tr...
T
Thomas Anderson 34 minutes ago
Treatment must begin early in life and before the onset of severe symptoms. SMA type 2 Type 2 causes...
S
Breathing difficulties are common and, in many cases, eventually fatal. As mentioned earlier, new treatments may prolong a person’s life. However, they will not reverse the symptoms a person already has.
Breathing difficulties are common and, in many cases, eventually fatal. As mentioned earlier, new treatments may prolong a person’s life. However, they will not reverse the symptoms a person already has.
thumb_up Like (11)
comment Reply (3)
thumb_up 11 likes
comment 3 replies
D
Daniel Kumar 2 minutes ago
Treatment must begin early in life and before the onset of severe symptoms. SMA type 2 Type 2 causes...
J
Jack Thompson 24 minutes ago
According to current data, 70% live to the age of 25 years, and some live even longer. As with the m...
K
Treatment must begin early in life and before the onset of severe symptoms. SMA type 2
Type 2 causes symptoms beginning at 6–18 months of age. Infants and children with this type usually have more mobility, including the ability to sit, and do not experience the same level of disability as those with types 0 and 1.
Treatment must begin early in life and before the onset of severe symptoms. SMA type 2 Type 2 causes symptoms beginning at 6–18 months of age. Infants and children with this type usually have more mobility, including the ability to sit, and do not experience the same level of disability as those with types 0 and 1.
thumb_up Like (45)
comment Reply (1)
thumb_up 45 likes
comment 1 replies
N
Nathan Chen 24 minutes ago
According to current data, 70% live to the age of 25 years, and some live even longer. As with the m...
L
According to current data, 70% live to the age of 25 years, and some live even longer. As with the more severe forms of SMA, emerging treatments may prolong the life expectancy of someone with SMA type 2.
According to current data, 70% live to the age of 25 years, and some live even longer. As with the more severe forms of SMA, emerging treatments may prolong the life expectancy of someone with SMA type 2.
thumb_up Like (47)
comment Reply (2)
thumb_up 47 likes
comment 2 replies
L
Luna Park 8 minutes ago
However, these treatments are new, so it is unclear how much they can affect lifespan. SMA type 3 SM...
S
Sophie Martin 38 minutes ago
Some individuals with type 3 have other disabilities or need assistive devices, such as wheelchairs,...
E
However, these treatments are new, so it is unclear how much they can affect lifespan. SMA type 3
SMA type 3 causes fewer mobility impairments. People with this form often can walk and do not typically have breathing difficulties.
However, these treatments are new, so it is unclear how much they can affect lifespan. SMA type 3 SMA type 3 causes fewer mobility impairments. People with this form often can walk and do not typically have breathing difficulties.
thumb_up Like (29)
comment Reply (3)
thumb_up 29 likes
comment 3 replies
M
Mason Rodriguez 7 minutes ago
Some individuals with type 3 have other disabilities or need assistive devices, such as wheelchairs,...
H
Hannah Kim 13 minutes ago
Factors affecting prognosis With early treatment, the prognosis of SMA may improve, and people can s...
S
Some individuals with type 3 have other disabilities or need assistive devices, such as wheelchairs, but the condition does not affect their life expectancy. SMA type 4
SMA type 4 is the least severe form of the disease, and people with this type may only have minimal mobility impairments. The life expectancy of someone with type 4 is similar to that of individuals without SMA.
Some individuals with type 3 have other disabilities or need assistive devices, such as wheelchairs, but the condition does not affect their life expectancy. SMA type 4 SMA type 4 is the least severe form of the disease, and people with this type may only have minimal mobility impairments. The life expectancy of someone with type 4 is similar to that of individuals without SMA.
thumb_up Like (45)
comment Reply (1)
thumb_up 45 likes
comment 1 replies
V
Victoria Lopez 16 minutes ago
Factors affecting prognosis With early treatment, the prognosis of SMA may improve, and people can s...
A
Factors affecting prognosis
With early treatment, the prognosis of SMA may improve, and people can survive for longer than those who do not receive treatment. Some factors affecting survival in the most severe types, which were once fatal, include: starting treatment before the age of 2 yearsnot having severe symptoms at the time therapy begins responding well to treatmentmanaging health complications, such as infections
 Improving life expectancy with SMA
Gene therapy may improve the life expectancy of someone with SMA. However, this technique is very new, and clinical trials have not lasted long enough to determine the average life expectancy following gene therapy.
Factors affecting prognosis With early treatment, the prognosis of SMA may improve, and people can survive for longer than those who do not receive treatment. Some factors affecting survival in the most severe types, which were once fatal, include: starting treatment before the age of 2 yearsnot having severe symptoms at the time therapy begins responding well to treatmentmanaging health complications, such as infections Improving life expectancy with SMA Gene therapy may improve the life expectancy of someone with SMA. However, this technique is very new, and clinical trials have not lasted long enough to determine the average life expectancy following gene therapy.
thumb_up Like (31)
comment Reply (1)
thumb_up 31 likes
comment 1 replies
Z
Zoe Mueller 28 minutes ago
Rispidlam and nusinersen, two other new drugs, can also extend the lifespan and improve the quality ...
Z
Rispidlam and nusinersen, two other new drugs, can also extend the lifespan and improve the quality of life for people with SMA. However, like gene therapy, these treatments are new, and it is unclear exactly how long they might prolong a person’s life. In the most severe forms of SMA, the outlook is better if someone receives treatment before developing symptoms.
Rispidlam and nusinersen, two other new drugs, can also extend the lifespan and improve the quality of life for people with SMA. However, like gene therapy, these treatments are new, and it is unclear exactly how long they might prolong a person’s life. In the most severe forms of SMA, the outlook is better if someone receives treatment before developing symptoms.
thumb_up Like (24)
comment Reply (1)
thumb_up 24 likes
comment 1 replies
I
Isaac Schmidt 55 minutes ago
Learn more about gene therapy for SMA. Summary There are five types of SMA, ranging from most severe...
A
Learn more about gene therapy for SMA. Summary
There are five types of SMA, ranging from most severe to least severe.
Learn more about gene therapy for SMA. Summary There are five types of SMA, ranging from most severe to least severe.
thumb_up Like (11)
comment Reply (0)
thumb_up 11 likes
N
Most forms cause significant disability and mobility impairments, though people with type 4 sometimes have only mild symptoms. Life expectancy depends on the SMA type a person has, which treatments they are eligible for, and how early they begin them. Parents or caregivers of children with SMA should seek specialist care from an expert and advocate for early intervention, especially if the child is eligible for gene therapy.
Most forms cause significant disability and mobility impairments, though people with type 4 sometimes have only mild symptoms. Life expectancy depends on the SMA type a person has, which treatments they are eligible for, and how early they begin them. Parents or caregivers of children with SMA should seek specialist care from an expert and advocate for early intervention, especially if the child is eligible for gene therapy.
thumb_up Like (39)
comment Reply (2)
thumb_up 39 likes
comment 2 replies
S
Scarlett Brown 30 minutes ago
Adults with SMA should continue to seek care from an expert healthcare team and ask about emerging a...
K
Kevin Wang 19 minutes ago
We link primary sources — including studies, scientific references, and statistics — within each...
G
Adults with SMA should continue to seek care from an expert healthcare team and ask about emerging and experimental therapies. Last medically reviewed on September 12, 2022GeneticsRespiratoryNeurology / NeurosciencePediatrics / Children's Health 5 sourcescollapsedMedical News Today has strict sourcing guidelines and draws only from peer-reviewed studies, academic research institutions, and medical journals and associations. We avoid using tertiary references.
Adults with SMA should continue to seek care from an expert healthcare team and ask about emerging and experimental therapies. Last medically reviewed on September 12, 2022GeneticsRespiratoryNeurology / NeurosciencePediatrics / Children's Health 5 sourcescollapsedMedical News Today has strict sourcing guidelines and draws only from peer-reviewed studies, academic research institutions, and medical journals and associations. We avoid using tertiary references.
thumb_up Like (34)
comment Reply (1)
thumb_up 34 likes
comment 1 replies
N
Noah Davis 115 minutes ago
We link primary sources — including studies, scientific references, and statistics — within each...
C
We link primary sources — including studies, scientific references, and statistics — within each article and also list them in the resources section at the bottom of our articles. You can learn more about how we ensure our content is accurate and current by reading our editorial policy.Burr, P., et al.
We link primary sources — including studies, scientific references, and statistics — within each article and also list them in the resources section at the bottom of our articles. You can learn more about how we ensure our content is accurate and current by reading our editorial policy.Burr, P., et al.
thumb_up Like (5)
comment Reply (1)
thumb_up 5 likes
comment 1 replies
T
Thomas Anderson 22 minutes ago
(2022). Spinal muscle atrophy.https://www.ncbi.nlm.nih.gov/books/NBK560687/Emmady, P....
J
(2022). Spinal muscle atrophy.https://www.ncbi.nlm.nih.gov/books/NBK560687/Emmady, P.
(2022). Spinal muscle atrophy.https://www.ncbi.nlm.nih.gov/books/NBK560687/Emmady, P.
thumb_up Like (25)
comment Reply (1)
thumb_up 25 likes
comment 1 replies
H
Henry Schmidt 47 minutes ago
D., et al. (2022)....
A
D., et al. (2022).
D., et al. (2022).
thumb_up Like (47)
comment Reply (2)
thumb_up 47 likes
comment 2 replies
V
Victoria Lopez 16 minutes ago
Werdnig Hoffman disease.https://www.ncbi.nlm.nih.gov/books/NBK558933/Reilly, A., et al. (2022). Curi...
I
Isaac Schmidt 41 minutes ago
(2018). Putting our best foot forward: Clinical, treatment-based and ethical considerations of nusin...
E
Werdnig Hoffman disease.https://www.ncbi.nlm.nih.gov/books/NBK558933/Reilly, A., et al. (2022). Curing SMA: Are we there yet?https://www.nature.com/articles/s41434-022-00349-yVukovic, S., et al.
Werdnig Hoffman disease.https://www.ncbi.nlm.nih.gov/books/NBK558933/Reilly, A., et al. (2022). Curing SMA: Are we there yet?https://www.nature.com/articles/s41434-022-00349-yVukovic, S., et al.
thumb_up Like (26)
comment Reply (1)
thumb_up 26 likes
comment 1 replies
N
Nathan Chen 9 minutes ago
(2018). Putting our best foot forward: Clinical, treatment-based and ethical considerations of nusin...
C
(2018). Putting our best foot forward: Clinical, treatment-based and ethical considerations of nusinersen therapy in Canada for spinal muscular atrophy [Abstract].https://onlinelibrary.wiley.com/doi/abs/10.1111/jpc.14226Wadman, R.
(2018). Putting our best foot forward: Clinical, treatment-based and ethical considerations of nusinersen therapy in Canada for spinal muscular atrophy [Abstract].https://onlinelibrary.wiley.com/doi/abs/10.1111/jpc.14226Wadman, R.
thumb_up Like (9)
comment Reply (0)
thumb_up 9 likes
C
I., et al. (2020).
I., et al. (2020).
thumb_up Like (23)
comment Reply (2)
thumb_up 23 likes
comment 2 replies
D
David Cohen 23 minutes ago
Drug treatment for spinal muscular atrophy types II and III.https://www.cochranelibrary.com/cdsr/doi...
T
Thomas Anderson 14 minutes ago
Their unusually large neuronsOmega-3 may provide a brain boost for people in midlifeSeasonal affecti...
J
Drug treatment for spinal muscular atrophy types II and III.https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006282.pub5/fullFEEDBACK:Medically reviewed by Heidi Moawad, M.D. — By Zawn Villines on September 12, 2022
 Latest newsWhat sets 'SuperAgers' apart?
Drug treatment for spinal muscular atrophy types II and III.https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006282.pub5/fullFEEDBACK:Medically reviewed by Heidi Moawad, M.D. — By Zawn Villines on September 12, 2022 Latest newsWhat sets 'SuperAgers' apart?
thumb_up Like (30)
comment Reply (3)
thumb_up 30 likes
comment 3 replies
K
Kevin Wang 14 minutes ago
Their unusually large neuronsOmega-3 may provide a brain boost for people in midlifeSeasonal affecti...
R
Ryan Garcia 24 minutes ago
It replaces the damaged SMN1 gene that causes SMA with a…READ MOREAll about spinal muscular atroph...
V
Their unusually large neuronsOmega-3 may provide a brain boost for people in midlifeSeasonal affective disorder (SAD): How to beat it this fall and winterCDC: Monkeypox in the US 'unlikely to be eliminated in the near future'Why are more women prone to Alzheimer's? New clues arise
 Related CoverageWhat to know about SMA gene therapy
Gene therapy may be a treatment option for some people with spinal muscular atrophy (SMA).
Their unusually large neuronsOmega-3 may provide a brain boost for people in midlifeSeasonal affective disorder (SAD): How to beat it this fall and winterCDC: Monkeypox in the US 'unlikely to be eliminated in the near future'Why are more women prone to Alzheimer's? New clues arise Related CoverageWhat to know about SMA gene therapy Gene therapy may be a treatment option for some people with spinal muscular atrophy (SMA).
thumb_up Like (19)
comment Reply (3)
thumb_up 19 likes
comment 3 replies
H
Harper Kim 11 minutes ago
It replaces the damaged SMN1 gene that causes SMA with a…READ MOREAll about spinal muscular atroph...
S
Scarlett Brown 8 minutes ago
Learn more.READ MOREWhat is the best medication for spinal arthritis? Medication can help reduce pai...
N
It replaces the damaged SMN1 gene that causes SMA with a…READ MOREAll about spinal muscular atrophy (SMA)Medically reviewed by Heidi Moawad, MD
Spinal muscular atrophy (SMA) is a collection of inherited neuromuscular diseases. Muscle weakness is the main symptom, and this can affect breathing…READ MOREWhat is muscular dystrophy?Medically reviewed by Angela M. Bell, MD, FACP
Muscular dystrophy is one of a group of genetic diseases characterized by progressive weakness and muscle degeneration.
It replaces the damaged SMN1 gene that causes SMA with a…READ MOREAll about spinal muscular atrophy (SMA)Medically reviewed by Heidi Moawad, MD Spinal muscular atrophy (SMA) is a collection of inherited neuromuscular diseases. Muscle weakness is the main symptom, and this can affect breathing…READ MOREWhat is muscular dystrophy?Medically reviewed by Angela M. Bell, MD, FACP Muscular dystrophy is one of a group of genetic diseases characterized by progressive weakness and muscle degeneration.
thumb_up Like (3)
comment Reply (0)
thumb_up 3 likes
A
Learn more.READ MOREWhat is the best medication for spinal arthritis? Medication can help reduce pain and improve mobility for people with spinal arthritis.
Learn more.READ MOREWhat is the best medication for spinal arthritis? Medication can help reduce pain and improve mobility for people with spinal arthritis.
thumb_up Like (18)
comment Reply (1)
thumb_up 18 likes
comment 1 replies
S
Scarlett Brown 27 minutes ago
Common types include acetaminophen (Tylenol) and nonsteroidal…READ MOREAll about autonomic dysrefl...
A
Common types include acetaminophen (Tylenol) and nonsteroidal…READ MOREAll about autonomic dysreflexia
Autonomic dysreflexia (AD) is a life threatening condition resulting from a spinal cord injury. Learn more about autonomic dysreflexia here.
Common types include acetaminophen (Tylenol) and nonsteroidal…READ MOREAll about autonomic dysreflexia Autonomic dysreflexia (AD) is a life threatening condition resulting from a spinal cord injury. Learn more about autonomic dysreflexia here.
thumb_up Like (25)
comment Reply (1)
thumb_up 25 likes
comment 1 replies
N
Nathan Chen 13 minutes ago
READ MORE...
A
READ MORE
READ MORE
thumb_up Like (30)
comment Reply (2)
thumb_up 30 likes
comment 2 replies
A
Alexander Wang 111 minutes ago
Spinal muscular atrophy (SMA) life expectancy: Types 0, 1, 2, 3, and 4 Health ConditionsHealth Condi...
J
James Smith 92 minutes ago
The above information comes from a 2018 study in the Journal of Pediatrics and Child Health. It is i...

Write a Reply